Variant report
Variant | esv15951 |
---|---|
Chromosome Location | chr1:195359744-195365244 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:195361839..195365274-chr1:195369633..195372261,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6690599 | chr1:195363004-195363005 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs187034602 | chr1:195363052-195363053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200529731 | chr1:195363117-195363118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79473878 | chr1:195363172-195363173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147792109 | chr1:195363173-195363174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555785047 | chr1:195363176-195363177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141164578 | chr1:195363181-195363182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189954149 | chr1:195363235-195363236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7512787 | chr1:195363289-195363290 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs150301843 | chr1:195363302-195363303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542834360 | chr1:195363312-195363313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546809591 | chr1:195363326-195363327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561047205 | chr1:195363340-195363341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531890058 | chr1:195363341-195363342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372286229 | chr1:195363370-195363371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6428283 | chr1:195363412-195363413 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs183240870 | chr1:195363453-195363454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs80009581 | chr1:195363504-195363505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7513072 | chr1:195363514-195363515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs73060238 | chr1:195363533-195363534 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs568524745 | chr1:195363585-195363586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187776103 | chr1:195363661-195363662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75019245 | chr1:195363702-195363703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149218818 | chr1:195363714-195363715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555797069 | chr1:195363719-195363720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185097550 | chr1:195363734-195363735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577580772 | chr1:195363770-195363771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544960968 | chr1:195363786-195363787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192646847 | chr1:195363846-195363847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560320951 | chr1:195363874-195363875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572338629 | chr1:195363916-195363917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542941549 | chr1:195363923-195363924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557430742 | chr1:195363976-195363977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79692387 | chr1:195363985-195363986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531494523 | chr1:195363991-195363992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185690929 | chr1:195363997-195363998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376624518 | chr1:195363998-195363999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143371896 | chr1:195364040-195364041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532480838 | chr1:195364058-195364059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547807650 | chr1:195364067-195364068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77202532 | chr1:195364086-195364087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530470060 | chr1:195364091-195364092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12136035 | chr1:195364118-195364119 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs187751500 | chr1:195364132-195364133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537210818 | chr1:195364154-195364155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374624407 | chr1:195364164-195364165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549487377 | chr1:195364170-195364171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571347007 | chr1:195364192-195364193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538339352 | chr1:195364220-195364221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371408933 | chr1:195364224-195364225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Gastric cancer | 22014070 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:195363000-195363400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr1:195363200-195364400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr1:195363800-195364400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr1:195364400-195367200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |